What's New
Last Posted: Mar 14, 2020
- Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer
JAMA Oncology, March 12, 2020 - A clinical approach to detecting germline pathogenic variants from tumor-only sequencing
OC Bersoy et al, JNCI Cancer Spetrum, March 2020 - Assessment of Treatment Cost-effectiveness Using a Colorectal Cancer Mutation Profile
TJ Yeatman et al, JAMA Netwotk Open, March 9, 2020 - Cost-effectiveness Evaluation of Targeted Surgical and Endoscopic Therapies for Early Colorectal Adenocarcinoma Based on Biomarker Profiles
SR Jang et al. JAMA Network Open, March 9, 2020 - Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study
S Klek et al, JNCI Cancer Spectrum - What Is Colorectal Cancer Screening?
CDC, March 2020 - Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer
Y Zheng et al, Nat comms, March 2020 - Whole tumor genomes across cancers.
et al. Nature genetics 2020 Mar (3) 241 - Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
T Fehlmann et al, JAMA Oncology, March 5, 2020 - Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
JNCI, March 2020 - The Challenges of Optimizing Biomarkers To Guide Clinical Decision Making
SM Hewitt JNCI, March 4, 2020 - Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms
T Schaffer et al, JAMA Network Open, March 2020 - A Turing test for artificial intelligence in cancer
Nature Cancer, February 2020 - Artificial intelligence and cancer
Nature Cancer, February 2020 - Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens
K Parikh et al, JAMA Network Open, February 28, 2020
.png)
No hay comentarios:
Publicar un comentario